Filter Results
:
(165)
Show Results For
-
All HBS Web
(952)
- Faculty Publications (165)
Show Results For
-
All HBS Web
(952)
- Faculty Publications (165)
Page 1 of
165
Results
→
- September 2024
- Case
Faena: Magic in Mid-Miami Beach
By: Robin Greenwood, Denise Han, Dave Habeeb and Ruth Page
The link to this multimedia case should be provided to students in advance as preparation for classroom case discussion.
This multimedia case follows real estate developer Alan Faena as he expanded his luxury development business from Argentina to the United States....
View Details
Keywords:
Development;
Real Estate;
Hotels;
Luxury;
Urban Development;
Sustainable Cities;
Design;
Markets;
Transformation;
Cost vs Benefits;
Economic Growth;
Private Sector;
Public Sector;
Economic Slowdown and Stagnation;
Cultural Entrepreneurship;
Financial Strategy;
Investment Return;
Geographic Location;
Urban Scope;
Corporate Accountability;
Collaborative Innovation and Invention;
Business and Community Relations;
Business and Government Relations;
Opportunities;
Culture;
Value Creation;
Real Estate Industry;
Entertainment and Recreation Industry;
Florida;
Miami;
Argentina;
Buenos Aires
Greenwood, Robin, Denise Han, Dave Habeeb, and Ruth Page. "Faena: Magic in Mid-Miami Beach." Harvard Business School Multimedia/Video Case 225-701, September 2024.
- 2024
- Working Paper
Markups and Cost Pass-through Along the Supply Chain
By: Santiago E. Alvarez, Alberto Cavallo, Alexander MacKay and Paolo Mengano
We study markups and pricing strategies along the supply chain. Our unique dataset combines detailed price and cost information from a large global manufacturer with matched retail prices collected online for the period July 2018 through June 2023. We show that total...
View Details
Alvarez, Santiago E., Alberto Cavallo, Alexander MacKay, and Paolo Mengano. "Markups and Cost Pass-through Along the Supply Chain." Harvard Business School Working Paper, No. 25-009, August 2024.
- June 2024 (Revised August 2024)
- Case
Cementos Argos in the U.S.: Go Big or Go Home?
By: Jorge Tamayo, Ruth Costas, Pedro Levindo and Karina Souza
In April 2011, Colombian group Cementos Argos had to decide on whether to double down its business in the U.S., amidst the U.S. cement industry’s lowest performance in 30 years. Argos— Colombia’s leading cement producer and one of the “jewels” of Grupo GEA, the...
View Details
Keywords:
Mergers and Acquisitions;
Business Organization;
Business Subsidiaries;
Talent and Talent Management;
Decision Making;
Cost vs Benefits;
Financial Crisis;
Cross-Cultural and Cross-Border Issues;
Global Strategy;
Strategy;
Manufacturing Industry;
Manufacturing Industry;
Latin America;
South America;
North and Central America;
United States;
Colombia
- May 2024
- Article
True Costs of Uterine Artery Embolization: Time-Driven Activity-Based Costing in Interventional Radiology Over a 3-Year Period
By: Julia C. Bulman, Nicole H. Kim, Robert S. Kaplan, Sarah Schroeppel DeBacker, Olga R. Brook and Ammar Sarwar
The study used time-driven activity-based costing (TDABC) to estimate the costs to perform uterine artery embolization (UAE). Utilization times for patients undergoing outpatient UAE for fibroids or adenomyosis were captured from electronic health record timestamps and...
View Details
Bulman, Julia C., Nicole H. Kim, Robert S. Kaplan, Sarah Schroeppel DeBacker, Olga R. Brook, and Ammar Sarwar. "True Costs of Uterine Artery Embolization: Time-Driven Activity-Based Costing in Interventional Radiology Over a 3-Year Period." Journal of the American College of Radiology 21, no. 5 (May 2024): 721–728.
- April 2024 (Revised July 2024)
- Case
Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs
By: Joseph L. Badaracco, Tom Quinn and John Schultz
Danish pharmaceutical company Novo Nordisk was owned by a charitable foundation, and since its founding in the 1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of...
View Details
Keywords:
Cost vs Benefits;
Decisions;
Judgments;
Values and Beliefs;
Global Strategy;
Health Care and Treatment;
Patents;
Growth and Development Strategy;
Growth Management;
Product Positioning;
Supply and Industry;
Supply Chain;
Corporate Social Responsibility and Impact;
Mission and Purpose;
Philanthropy and Charitable Giving;
Opportunities;
Social Issues;
Equality and Inequality;
Pharmaceutical Industry;
Health Industry;
Denmark;
United States;
Europe;
China;
India;
Middle East;
North Africa
Badaracco, Joseph L., Tom Quinn, and John Schultz. "Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs." Harvard Business School Case 324-114, April 2024. (Revised July 2024.)
- October 2023 (Revised January 2024)
- Case
Ball: EVA Driving the World's Leading Can Manufacturer (A)
By: Jonas Heese and Susan Pinckney
The case describes Ball’s multi decade history of using Economic Value Added to drive decision making and workforce compensation. In 2016, the company acquired Rexam PLC and became the world’s leading metal beverage container company. Consumer demand for varied...
View Details
Keywords:
Budgets and Budgeting;
Cost Accounting;
Financial Reporting;
Financial Statements;
Buildings and Facilities;
Green Building;
Mergers and Acquisitions;
Customer Satisfaction;
Decisions;
Forecasting and Prediction;
Machinery and Machining;
Asset Pricing;
Corporate Finance;
Capital;
Cost;
Financial Management;
Goods and Commodities;
Compensation and Benefits;
Executive Compensation;
Employee Relationship Management;
Goals and Objectives;
Resource Allocation;
Business Strategy;
Corporate Strategy;
Food and Beverage Industry;
United States;
Arizona;
California;
Texas
Heese, Jonas, and Susan Pinckney. "Ball: EVA Driving the World's Leading Can Manufacturer (A)." Harvard Business School Case 124-002, October 2023. (Revised January 2024.)
- September–October 2023
- Article
The New Era of Industrial Policy Is Here
By: Willy C. Shih
Governments around the world are increasingly intervening in the private sector through industrial policies designed to help domestic sectors reach goals that markets alone are unlikely to achieve. Companies in targeted sectors—such as automakers, energy companies, and...
View Details
Keywords:
Policy;
Government and Politics;
Business and Government Relations;
Research and Development;
Economic Sectors
Shih, Willy C. "The New Era of Industrial Policy Is Here." Harvard Business Review 101, no. 5 (September–October 2023): 66–75.
- April 2023
- Article
The Real Exchange Rate, Innovation and Productivity
By: Laura Alfaro, Alejandro Cuñat, Harald Fadinger and Yanping Liu
We evaluate manufacturing firms' responses to changes in the real exchange rate (RER) using detailed firm-level data for a large set of countries for the period 2001-2010. We uncover the following stylized facts about regional variation of manufacturing firms'...
View Details
Keywords:
Real Exchange Rate;
Firm Level Data;
Innovation;
Productivity;
Exporting;
Importing;
Credit Constraints;
Currency Exchange Rate;
Innovation and Invention;
Performance Productivity
Alfaro, Laura, Alejandro Cuñat, Harald Fadinger, and Yanping Liu. "The Real Exchange Rate, Innovation and Productivity." Journal of the European Economic Association 21, no. 2 (April 2023): 637–689.
- February 2023
- Case
Graphic Packaging: Project Cowboy (A)
By: Benjamin C. Esty and E. Scott Mayfield
In July 2019, Graphic Packaging CEO Michael Doss was proposing a $600 million investment in a new machine to produce coated recycled board (CRB), a type of paper packaging used for consumer products (cups, cereal boxes, beverage boxes, etc.) that utilized recycled...
View Details
Keywords:
Capital Budgeting;
Growth Management;
Demand and Consumers;
Duopoly and Oligopoly;
Competitive Strategy;
Competitive Advantage;
Expansion;
Value Creation;
Supply and Industry;
Manufacturing Industry;
Manufacturing Industry;
United States;
North America
Esty, Benjamin C., and E. Scott Mayfield. "Graphic Packaging: Project Cowboy (A)." Harvard Business School Case 223-009, February 2023.
- February 2023
- Supplement
Graphic Packaging: Project Cowboy (A) Courseware
By: Benjamin C. Esty and Scott Mayfield
In July 2019, Graphic Packaging CEO Michael Doss was proposing a $600 million investment in a new machine to produce coated recycled board (CRB), a type of paper packaging used for consumer products (cups, cereal boxes, beverage boxes, etc.) that utilized recycled...
View Details
- January 2023
- Case
Velong: Rethinking 'Made in China'
By: Krishna G. Palepu, Nancy Hua Dai and Billy Chan
Velong is a supplier of kitchen equipment and backyard grills for major global brands and store brands of large western retailers. In light of the COVID-related disruptions to the global supply chains, and the evolving trade tensions between China and the Western...
View Details
Keywords:
Globalization;
Supply Chain Management;
Risk Management;
Manufacturing Industry;
China;
India;
Mexico;
Turkey;
Viet Nam
Palepu, Krishna G., Nancy Hua Dai, and Billy Chan. "Velong: Rethinking 'Made in China'." Harvard Business School Case 323-064, January 2023.
- September 2022
- Article
Giving a Buck or Making a Buck? Donations by Pharmaceutical Manufacturers to Independent Patient Assistance Charities
By: Leemore Dafny, Christopher Ody and Teresa Rokos
The federal Anti-Kickback Statute prohibits biopharmaceutical manufacturers from directly covering Medicare enrollees’ out-of-pocket spending for the drugs they manufacture, but manufacturers may donate to independent patient assistance charities and earmark donations...
View Details
Keywords:
Cost Sharing;
Prescription Drugs;
Drug Spending;
Medicare;
Dual Eligibility;
Cost;
Health Care and Treatment;
Philanthropy and Charitable Giving;
Pharmaceutical Industry
Dafny, Leemore, Christopher Ody, and Teresa Rokos. "Giving a Buck or Making a Buck? Donations by Pharmaceutical Manufacturers to Independent Patient Assistance Charities." Health Affairs 41, no. 9 (September 2022).
- 2023
- Working Paper
Can Evidence-Based Information Shift Preferences Towards Trade Policy?
By: Laura Alfaro, Maggie X. Chen and Davin Chor
We investigate the role of evidence-based information in shaping individuals' preferences for trade policies through a series of survey experiments that contain randomized information treatments. Each treatment provides a concise statement of economics research...
View Details
Alfaro, Laura, Maggie X. Chen, and Davin Chor. "Can Evidence-Based Information Shift Preferences Towards Trade Policy?" Harvard Business School Working Paper, No. 22-062, March 2022. (Revised May 2023. NBER Working Paper Series, No. 31240, May 2023)
- March 2022
- Case
Unilever: Remote Work in Manufacturing
By: Prithwiraj Choudhury and Susie L. Ma
In December 2021, Unilever—one of the world’s largest producers of consumer goods—was in the midst of a pilot project to digitize its manufacturing facilities and enable remote work for factory employees. This was possible because of an earlier project to retrofit a...
View Details
Keywords:
Change;
Globalization;
Information Technology;
Technology Adoption;
Human Resources;
Jobs and Positions;
Operations;
Education;
Training;
Manufacturing Industry
Choudhury, Prithwiraj, and Susie L. Ma. "Unilever: Remote Work in Manufacturing." Harvard Business School Case 622-030, March 2022.
- March 2022
- Teaching Note
Digital Manufacturing at Amgen
By: Shane Greenstein, Kyle R. Myers and Sarah Mehta
This teaching note provides guidance for instructors teaching “Digital Manufacturing at Amgen,” case no. 621-008.
View Details
Keywords:
Change;
Change Management;
Decision Making;
Cost vs Benefits;
Decisions;
Information Technology;
Analytics and Data Science;
Innovation and Invention;
Innovation and Management;
Innovation Leadership;
Innovation Strategy;
Technological Innovation;
Jobs and Positions;
Knowledge;
Leadership;
Organizational Culture;
Science;
Strategy;
Technology Adoption;
Biotechnology Industry;
Pharmaceutical Industry;
United States;
California;
Puerto Rico;
Rhode Island
- December 2021 (Revised January 2023)
- Case
Katerra (A)
By: Lindsay N. Hyde, Thomas R. Eisenmann and Tom Quinn
In April 2020, Katerra executives struggled with a series of decisions that would determine the fate of one of the best-funded construction startups in history. Katerra was founded in 2015 by technology-industry executive Michael Marks and commercial real estate...
View Details
Keywords:
Business Startups;
Insolvency and Bankruptcy;
Entrepreneurship;
Failure;
Construction;
Real Estate Industry;
Technology Industry;
United States
Hyde, Lindsay N., Thomas R. Eisenmann, and Tom Quinn. "Katerra (A)." Harvard Business School Case 822-021, December 2021. (Revised January 2023.)
- Article
Accounting for Climate Change
By: Robert S. Kaplan and Karthik Ramanna
Corporations are facing growing pressure—from investors, advocacy groups, politicians, and even business leaders themselves—to reduce greenhouse gas (GHG) emissions from their operations and their supply and distribution chains. About 90% of the companies in the S&P...
View Details
Keywords:
Greenhouse Gas Mitigation;
Social Accounting;
E-liabilities;
Business And The Environment;
Climate Change;
Corporate Social Responsibility and Impact;
Environmental Sustainability
Kaplan, Robert S., and Karthik Ramanna. "Accounting for Climate Change." Harvard Business Review 99, no. 6 (November–December 2021): 120–131.
- September 2021 (Revised October 2022)
- Supplement
Hester Pharmaceuticals (B): Securing Supply
By: Dante Roscini and John Masko
Supplements the (A) case. In late 2020, demand for Hester Pharmaceutical’s (Hester’s) breakthrough oncology drug Akrozumab was outstripping the company’s most optimistic projections. In order to increase manufacturing capacity and meet the demand, Hester was...
View Details
Keywords:
COVID-19 Pandemic;
Cost vs Benefits;
Trade;
Supply Chain;
Global Strategy;
Buildings and Facilities;
Operations;
Health Care and Treatment;
Demand and Consumers;
Global Range;
Globalized Markets and Industries;
Pharmaceutical Industry;
Italy;
China;
United States;
Germany
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (B): Securing Supply." Harvard Business School Supplement 722-009, September 2021. (Revised October 2022.)
- August 2021 (Revised November 2023)
- Teaching Note
Coats: Supply Chain Challenges
By: Willy C. Shih
Teaching Note for HBS Case No. 621-115.
Faced with continuing cost pressure, should Coats, the world's largest thread maker, relocate some of its make-to-stock manufacturing to an ultra-low-cost region while leaving make-to-order demand close to customers?
View Details
- Summer 2021
- Article
The Cost and Evolution of Quality at Cipla Ltd, 1935–2016
By: Muhammad H. Zaman and Tarun Khanna
This article examines the evolution of Indian pharmaceutical manufacturer Cipla towards producing drugs that met the quality standards of European and U.S. regulators. It employs new research in Cipla’s corporate archives, the Creating Emerging Markets database, and...
View Details
Keywords:
Cipla;
Pharmaceuticals;
Drug Quality;
Generics;
Quality;
Standards;
Information Technology;
Cost;
Organizational Culture;
Business History;
Pharmaceutical Industry;
India
Zaman, Muhammad H., and Tarun Khanna. "The Cost and Evolution of Quality at Cipla Ltd, 1935–2016." Business History Review 95, no. 2 (Summer 2021): 249–274.